Celgene Corporation

(

CELG

) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 0.2%. By the end of trading, Celgene Corporation fell 82 cents (-1.3%) to $61.23 on average volume. Throughout the day, 3.2 million shares of Celgene Corporation exchanged hands as compared to its average daily volume of 3.7 million shares. The stock ranged in price between $61.08-$62.70 after having opened the day at $62.27 as compared to the previous trading day's close of $62.05. Other company's within the Health Care sector that declined today were:

DARA Biosciences Inc

(

DARA

), down 23%,

Accelr8 Technology Corporation

(

AXK

), down 15.1%,

Marshall Edwards Inc

(

MSHL

), down 13.9%, and

Response Genetics Inc

(

RGDX

), down 13.8%.

Celgene Corporation, an integrated biopharmaceutical company, discovers, develops, and commercializes various therapies to treat cancer and immune-inflammatory related diseases. Celgene Corporation has a market cap of $26.74 billion and is part of the

drugs

industry. The company has a P/E ratio of 25.3, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 4.9% year to date as of the close of trading on Monday.

TheStreet Ratings rates Celgene as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the positive front,

Marina Biotech Inc

(

MRNA

), up 22.9%,

Inhibitex Inc

(

INHX

), up 20.2%,

YM Biosciences Inc

(

YMI

), up 19.8%, and

Dehaier Medical Systems

(

DHRM

), up 14.3%, were all gainers within the health care sector with

Aetna Inc

(

AET

) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

null